Showing results (381-390 of 403) with videos related to
Sort By:
Pageof 41
Synapse (New York, N.Y.)|December 3, 2009
Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptorElliott J Sally, Heng Xu, Christina M Dersch, et al.Journal of Medicinal Chemistry|October 26, 2018
Preclinical Evaluation of the First Adenosine A<sub>1</sub> Receptor Partial Agonist Radioligand for Positron Emission Tomography ImagingMin Guo, Zhan-Guo Gao, Ryan Tyler, et al.ACS Chemical Neuroscience|May 20, 2025
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico StudyDelmis E Hernandez, Dan Luo, Thomas E Prisinzano, et al.Molecules (Basel, Switzerland)|March 10, 2022
Design, Synthesis, and In Vivo Evaluation of C1-Linked 4,5-Epoxymorphinan Haptens for Heroin VaccinesAgnieszka Sulima, Fuying Li, Jeffrey Brian Morgan, et al.Biological Psychiatry|February 20, 2013
Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring ratsJesse R Schank, Jenica D Tapocik, Estelle Barbier, et al.The Journal of Pharmacology and Experimental Therapeutics|January 11, 2023
Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin ReceptorSara L Deschaine, Morten A Hedegaard, Claire L Pince, et al.Cell Metabolism|July 31, 2012
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistanceJoseph Tam, Resat Cinar, Jie Liu, et al.Organic & Biomolecular Chemistry|April 5, 2007
Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonistsKejun Cheng, In Jong Kim, Mei-Jing Lee, et al.Frontiers in Pain Research (Lausanne, Switzerland)|September 30, 2022
Involvement of TLR2-TLR4, NLRP3, and IL-17 in pain induced by a novel Sprague-Dawley rat model of experimental autoimmune encephalomyelitisAndrew J Kwilasz, Madison A Clements, Tracey A Larson, et al.The Journal of Pharmacology and Experimental Therapeutics|January 13, 2009
Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and miceGregory T Collins, Andrew Truccone, Faiza Haji-Abdi, et al.Pageof 41